Villarino AV, Kanno Y, O’Shea JJ. Mechanisms and consequences of Jak–STAT signaling in the immune system. Nat Immunol. 2017;18(4):374–84. https://doi.org/10.1038/ni.3691.

Article  CAS  PubMed  Google Scholar 

Philips RL, Wang Y, Cheon H, et al. The JAK-STAT pathway at 30: much learned, much more to do. Cell. 2022;185(21):3857–76. https://doi.org/10.1016/j.cell.2022.09.023.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tangye SG, Al-Herz W, Bousfiha A, et al. Human inborn errors of immunity: 2022 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2022;42(7):1473–507. https://doi.org/10.1007/s10875-022-01289-3.

Article  PubMed  PubMed Central  Google Scholar 

Zhao Q, Dai R, Li Y, et al. Trends in TREC values according to age and gender in Chinese children and their clinical applications. Eur J Pediatr. 2021;181(2):529–38. https://doi.org/10.1007/s00431-021-04223-8.

Article  CAS  PubMed  Google Scholar 

Dion ML, Sékaly RP, Cheynier R. Estimating thymic function through quantification of T-Cell receptor excision circles. Methods Mol Bio. 2007;380:197–213. https://doi.org/10.1007/978-1-59745-395-0_12.

Article  CAS  Google Scholar 

Sottini A, Serana F, Bertoli D et al. Simultaneous quantification of T-cell receptor excision circles (TRECs) and K-deleting recombination excision circles (KRECs) by real-time PCR. J Vis Exp. 2014(94). https://doi.org/10.3791/52184.

Lv G, Sun G, Wu P, et al. Novel mutations of TYK2 leading to divergent clinical phenotypes. Pediatr Allergy Immunol. 2022;33(1):e13671. https://doi.org/10.1111/pai.13671.

Article  CAS  PubMed  Google Scholar 

Ding Y, Zhou L, Xia Y, et al. Reference values for peripheral blood lymphocyte subsets of healthy children in China. J Allergy Clin Immunol. 2018;142(3):970–e38. https://doi.org/10.1016/j.jaci.2018.04.022.

Article  PubMed  Google Scholar 

Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. diagnosis and staging working group report. Biol Blood Marrow Transpl. 2005;11(12):945–56. https://doi.org/10.1016/j.bbmt.2005.09.004.

Article  Google Scholar 

Ogishi M, Arias AA, Yang R, et al. Impaired IL-23-dependent induction of IFN-γ underlies mycobacterial disease in patients with inherited TYK2 deficiency. J Exp Med. 2022;219(10). https://doi.org/10.1084/jem.20220094.

Kreins AY, Ciancanelli MJ, Okada S, et al. Human TYK2 deficiency: mycobacterial and viral infections without hyper-IgE syndrome. J Exp Med. 2015;212(10):1641–62. https://doi.org/10.1084/jem.20140280.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nemoto M, Hattori H, Maeda N, et al. Compound heterozygous TYK2 mutations underlie primary immunodeficiency with T-cell lymphopenia. Sci Rep. 2018;8(1):6956. https://doi.org/10.1038/s41598-018-25260-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roussel L, Pham-Huy A, Yu AC, et al. A novel homozygous mutation causing Complete TYK2 Deficiency, with severe respiratory viral infections, EBV-Driven Lymphoma, and Jamestown Canyon viral encephalitis. J Clin Immunol. 2023;43(8):2011–21. https://doi.org/10.1007/s10875-023-01580-x.

Article  CAS  PubMed  Google Scholar 

Minegishi Y, Saito M, Morio T, et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity. 2006;25(5):745–55. https://doi.org/10.1016/j.immuni.2006.09.009.

Article  CAS  PubMed  Google Scholar 

Boisson-Dupuis S, Ramirez-Alejo N, Li Z, et al. Tuberculosis and impaired IL-23-dependent IFN-γ immunity in humans homozygous for a common TYK2 missense variant. Sci Immunol. 2018;3(30). https://doi.org/10.1126/sciimmunol.aau8714.

Zhang Q, Matuozzo D, Le Pen J, et al. Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia. J Exp Med. 2022;219(8):e20220131. https://doi.org/10.1084/jem.20220131.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo W, Feng X, Yang M, et al. Mycobacterium Intracellulare Infection Associated with TYK2 Deficiency: a Case Report and Review of the literature. Infect Drug Resist. 2020;13:4347–53. https://doi.org/10.2147/idr.S279438.

Article  PubMed  PubMed Central  Google Scholar 

Wu P, Chen S, Wu B, et al. A TYK2 gene mutation c.2395G > A leads to TYK2 Deficiency: a Case Report and Literature Review. Front Pediatr. 2020;8:253. https://doi.org/10.3389/fped.2020.00253.

Article  PubMed  PubMed Central  Google Scholar 

Sarrafzadeh S, Mahloojirad M, Casanova J, et al. A new patient with inherited TYK2 Deficiency. J Clin Immunol. 2020;40(1):232–5. https://doi.org/10.1007/s10875-019-00713-5.

Article  PubMed  Google Scholar 

Kilic SS, Hacimustafaoglu M, Boisson-Dupuis S, et al. A patient with tyrosine kinase 2 Deficiency without Hyper-IgE Syndrome. J Pediatr. 2012;160(6):1055–7. https://doi.org/10.1016/j.jpeds.2012.01.056.

Article  PubMed  PubMed Central  Google Scholar 

Fuchs S, Kaiser-Labusch P, Bank J, et al. Tyrosine kinase 2 is not limiting human antiviral type III interferon responses. Eur J Immunol. 2016;46(11):2639–49. https://doi.org/10.1002/eji.201646519.

Article  CAS  PubMed  Google Scholar 

Muromoto R, Oritani K, Matsuda T. Current understanding of the role of tyrosine kinase 2 signaling in immune responses. World J Biol Chem. 2022;13(1):1–14. https://doi.org/10.4331/wjbc.v13.i1.1.

Article  PubMed  PubMed Central  Google Scholar 

Nishio H, Matsui K, Tsuji H, et al. Expression of the janus kinases-signal transducers and activators of transcription pathway in Hassall’s corpuscles of the human thymus. Histochem Cell Biol. 2000;113(6):427–31. https://doi.org/10.1007/s004180000142.

Article  CAS  PubMed  Google Scholar 

Dell’Orso G, Bagnasco F, Giardino S, et al. Hematopoietic stem cell transplantation for inborn errors of immunity: 30-year single-center experience. Front Immunol. 2023;14:1103080. https://doi.org/10.3389/fimmu.2023.1103080.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Castagnoli R, Delmonte O, Calzoni E, et al. Hematopoietic stem cell transplantation in primary Immunodeficiency diseases: current status and future perspectives. Front Pediatr. 2019;7:295. https://doi.org/10.3389/fped.2019.00295.

Article  PubMed  PubMed Central  Google Scholar 

Laberko A, Gennery A. Clinical considerations in the hematopoietic stem cell transplant management of primary immunodeficiencies. Expert Rev Clin Immunol. 2018;14(4):297–306. https://doi.org/10.1080/1744666x.2018.1459189.

Article  CAS  PubMed  Google Scholar 

Chang TY, Jaing TH, Lee WI, et al. Single-institution experience of unrelated cord blood transplantation for primary immunodeficiency. J Pediatr Hematol Oncol. 2015;37(3). https://doi.org/10.1097/MPH.0000000000000232.

Lankester A, Albert M, Booth C, et al. EBMT/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity. Bone Marrow Transpl. 2021;56(9):2052–62. https://doi.org/10.1038/s41409-021-01378-8.

Article  CAS  Google Scholar 

Kreins A, Velasco H, Cheong K, et al. Long-term Immune Recovery after hematopoietic stem cell transplantation for ADA Deficiency: a single-center experience. J Clin Immunol. 2022;42(1):94–107. https://doi.org/10.1007/s10875-021-01145-w.

Article  CAS  PubMed  Google Scholar 

Laberko A, Deordieva E, Krivan G, et al. Multicenter Experience of hematopoietic stem cell transplantation in WHIM Syndrome. J Clin Immunol. 2022;42(1):171–82. https://doi.org/10.1007/s10875-021-01155-8.

Article  CAS  PubMed  Google Scholar